Multiple studies since 2012 have investigated GCase and its lipid substrates in GBA1-PD, and idiopathic PD, to better understand how GBA1 mutations impact enzyme activity and lipid status, and determine if this enzyme is also impacted in individuals without mutations16–19,23–26 (Supplementary Fig. 1). This evidence concerns the gene GBA1 and Parkinson disease.